文献速递MDS 与骨髓增殖性肿瘤白血病

干性信号与干扰素信号比值作为骨髓增殖性肿瘤进展为急性髓系白血病的生物标志物和治疗靶点

Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia.
PubMed 文献 · Br J Haematol · 2023-09-19

该研究探讨骨髓增殖性肿瘤(MPN)向继发性急性髓系白血病(sAML)进展中干扰素(IFN)信号与白血病干细胞(LSC)信号的关系。发现高IFN信号与低LSC信号相关,进展时IFN信号降低而LSC特征升高;LSC与IFN表达比值高与不良预后及更高集落形成能力相关。去甲基化药物(HMA)通过诱导病毒模拟反应激活IFN信号,降低LSC特征,提示该比值可作为进展生物标志物。

要点

  • MPN和AML样本中高IFN信号与低LSC信号相关,进展时IFN信号降低而LSC特征升高。
  • MPN患者中高LSC/IFN表达比值与不良临床预后和更高集落形成能力相关。
  • HMA通过诱导dsRNA形成和MDA5/RIG-I激活来激活IFN信号,降低LSC特征和干性。

核心结论

  • MPN向sAML进展伴随病毒模拟反应逃逸,LSC与IFN表达比值可作为进展生物标志物。
  • HMA治疗可在小鼠模型中通过重新激活dsRNA相关IFN信号导致血液学反应。

研究设计与样本

  • 研究检测了MPN和AML样本中IFN信号与LSC信号的相关性,并分析MPN患者中LSC/IFN比值与临床预后及集落形成能力的关系。
  • 研究还使用HMA处理MPN细胞,检测病毒模拟反应、dsRNA形成、MDA5/RIG-I激活及LSC特征变化,并在小鼠模型中进行评估。

主要发现

  • MPN和AML样本中高IFN信号与低LSC信号相关。
  • MPN进展和AML转化以IFN信号降低和LSC特征升高为特征。
  • MPN患者中高LSC/IFN表达比值与不良临床预后和更高集落形成能力相关。
  • HMA处理通过诱导dsRNA形成和MDA5/RIG-I激活来激活MPN细胞中的IFN信号通路。
  • HMA诱导的IFN反应导致LSC特征降低,干性降低。

临床怎么用

  • 作者认为LSC与IFN表达比值可作为MPN进展的生物标志物。
  • 作者提示HMA治疗可在小鼠模型中通过重新激活dsRNA相关IFN信号导致血液学反应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Progression to aggressive secondary acute myeloid leukaemia (sAML) poses a significant challenge in the management of myeloproliferative neoplasms (MPNs). Since the physiopathology of MPN is closely linked to the activation of interferon (IFN) signalling and that AML initiation and aggressiveness is driven by leukaemia stem cells (LSCs), we investigated these pathways in MPN to sAML progression. We found that high IFN signalling correlated with low LSC signalling in MPN and AML samples, while MPN progression and AML transformation were characterized by decreased IFN signalling and increased LSC signature. A high LSC to IFN expression ratio in MPN patients was associated with adverse clinical prognosis and higher colony forming potential. Moreover, treatment with hypomethylating agents (HMAs) activates the IFN signalling pathway in MPN cells by inducing a viral mimicry response. This response is characterized by double-stranded RNA (dsRNA) formation and MDA5/RIG-I activation. The HMA-induced IFN response leads to a reduction in LSC signature, resulting in decreased stemness. These findings reveal the frequent evasion of viral mimicry during MPN-to-sAML progression, establish the LSC-to-IFN expression ratio as a progression biomarker, and suggests that HMAs treatment can lead to haematological response in murine models by re-activating dsRNA-associated IFN signalling.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. de Castro FA, Mehdipour P, Chakravarthy A, et al. Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia. Br J Haematol. 2023. PMID: 37726227. doi:10.1111/bjh.19107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。